CD4+ CD25+ regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model

Cytotherapy

Volumn 13, Issue 7, 2011, Pages 835-847

  Shim, Jua ^a   Lee, Eun So ^b   Park, Sun ^b   Bang, Dongsik ^c   Sohn, Seonghyang ^a,d  

^a Ajou University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Yonsei University   (South Korea)

^d Brain Korea 21 Project for Medical Science   (South Korea)

Author keywords

Behcet's disease; Herpes simplex virus; Mouse model; Regulatory T cells; Systemic inflammation

Indexed keywords

BETA ACTIN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHCET DISEASE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DETERIORATION; DISEASE SEVERITY; DOWN REGULATION; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; INFLAMMATION; INOCULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; SYMPTOM; UPREGULATION;

EID: 84860390324     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.571245     Document Type: Article

References (66)

1. Shimizu T. Behcet disease (Behcet syndrome). Semin Arthritis Rheum. 1979;8:223-60.
2. Behcet H. Ueber rezidivierende, aphthoese durch ein Virus verursachte Geschwuere am Mund, am Auge und an den Genitalien. Dermatol Wochenschr. 1937;105:1152-7.
3. Lee S, Bang D, Cho YH, Lee ES, Sohn S. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet's disease. Arch Dermatol Res. 1996;288:179-83.
4. Lee ES, Lee S, Bang D, Sohn S, Park C, Lee K. Herpes simplex virus detection by polymerase chain reaction in intestinal ulcer of patients with Behcet's disease. J Invest Dermatol. 1993;101:474
5. Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S. Epidemiological and clinical features of Behcet's disease in Korea. Yonsei Med J. 1997;38:428-36.
6. Lee ES, Lee S, Bang D, Sohn S. Detection of herpes simplex virus DNA by polymerase chain reaction in genital ulcer of patients with Behcet's disease. Revue du Rhumatisme. 1996;63:532
7. Sohn S, Lee ES, Bang D, Lee S. Behçet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol. 1998;8:21-3.
8. Kim HJ, Bang D, Lee SH, Yang DS, Kim DH, Lee KH, et al. Behcet's syndrome in Korea: A look at the clinical picture. Yonsei Med J. 1988;29:72-8.
9. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151-64.
10. Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345-52.
11. Piccirillo CA, Shevach EM. Naturally-occurring CD4+ CD25+ immunoregulatory T cells: Central players in the arena of peripheral tolerance. Semin Immunol. 2004;16:81-8.
12. Thompson C, Powrie F. Regulatory T cells. Curr Opin Pharmacol. 2004;4:408-14.
13. Stephens GL, Shevach EM. Foxp3+ regulatory T cells: Selfi shness under scrutiny. Immunity. 2007;27:417-9.
14. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4+ CD25+ T cells with regulatory properties from human blood. J Exp Med. 2001;193:1303-10.
15. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: Human CD25(+ ) regulatory T cells convey suppressor activity to conventional CD4(+ ) T helper cells. J Exp Med. 2002;196:255-60.
16. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, et al. Multiple immunoregulatory defects in type-1 diabetes. J Clin Invest. 2002;109:131-40.
17. Amelsfort J, Jacvobs K, Bijlsma J, Lafeber F, Taams L. CD4+ CD25+ regulatory T cells in rheumatoid arthritis: Difference in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004;50:2775-85.
18. Cao D. Isolation and functional characterization of regulatory CD25 bright CD4 T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003;33:215-23.
19. Crispin JC, Martinez A, Varela JA. Quantifi cation of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun. 2003;21:273-6.
20. Sakaguchi S, Sakaguchi N, Shimizu J. Immunological tolerance maintained by CD25+ CD4+ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001;182:18-32.
21. Nanke Y, Kotake S, Goto M, Ujihara H, Matsubara M, Kamatani N. Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: A possible predictive marker of ocular attack. Mod Rheumatol. 2008;18:354-8.
22. Kimura A, Naka T, Kishimoto T. IL-6-dependent and -independent pathways in the development of interleukin 17- producing T helper cells. Proc Natl Acad Sci USA. 2007; 104:12099-104.
23. Murray LJ, Lee R, Martens C. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur J Immunol. 1990;20:163-70.
24. Derynck R, Jarrett JA, Chen EY, Goeddel DV. The murine transforming growth factor-beta precursor. J Biol Chem. 1986;261:4377-9.
25. Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol. 2008;9:166-75.
26. Yamaguchi Y, Fujio K, Shoda H, Okamoto A, Tsuno NH, Takahashi K, et al. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of infl ammatory arthritis. J Immunol. 2007;179:7128-36.
27. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4+ CD25+ regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med. 2002;196:247-53.
28. Papiernik M, do Carmo Leite-de-Moraes M, Pontoux C, Joret AM, Rocha B, Penit C, et al. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity. J Immunol. 1997;158:4642-53.
29. Stephens LA, Mottet C, Mason D, Powrie F. Human CD4(+ ) CD25(+ ) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol. 2001;31:1247-54.
30. Kulkarni AB, Karlsson S. Transforming growth factor-beta-1 knockout mice: A mutation in one cytokine gene causes a dramatic infl ammatory disease. Am J Pathol. 1993;143:3-9.
31. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal infl ammatory disease. Nature. 1992;359:693-9.
32. Sohn S, Lee ES, Kwon HJ, Lee SI, Bang D, Lee S. Expression of Th2 cytokines decreases the development of and improves Beh ç et's disease-like symptoms induced by herpes simplex virus in mice. J Infect Dis. 2001;183:1180-6.
33. Akdeniz N, Esrefoglu M, KeleşMS, Karakuzu A, Atasoy M. Serum interleukin-2, interleukin-6, tumour necrosis factoralpha and nitric oxide levels in patients with Behcet's disease. Ann Acad Med Singapore. 2004;33:596-9.
34. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR. TGF-beta induces a regulatory phenotype in CD4+ CD25-T cells through Foxp3 induction and down-regulation of Smad7. J Immunol. 2004;172:5149-53.
35. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune infl ammation. J Exp Med. 2005;201:233-40.
36. Matusevicius D, Kivisäkk P, He B, Kostulas N, Ozenci V, Fredrikson S, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. 1999;5:101-4.
37. Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinfl ammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus. 2000;9:589-93.
38. Hashimoto T, Akiyama K, Kobayashi N, Mori A. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int Arch Allergy Immunol. 2005;137:51-4.
39. Lindén A, Hoshino H, Laan M. Airway neutrophils and interleukin- 17. Eur Respir J. 2000;15:973-7.
40. Ricciardelli I, Lindley KJ, Londei M, Quaratino S. Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease. Immunology. 2008;125:178-83.
41. Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, et al. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res. 2005;81:45-52.
42. Lee HY, Hong YK, Yun HJ, Kim YM, Kim JR, Yoo WH. Altered frequency and migration capacity of CD4+ CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford). 2008;47:789-94.
43. Morgan ME, Flierman R, van Duivenvoorde LM, Witteveen HJ, van Ewijk W, van Laar JM, et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheu. 2005;52:2212-21.
44. Begum-Haque S, Sharma A, Kasper IR, Foureau DM, Mielcarz DW, Haque A, et al. Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2008;204:58-65.
45. Han GM, O'Neil-Andersen NJ, Zurier RB, Lawrence DA. CD4+ CD25 high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol. 2008;253:92-101.
46. Frimpong-Boateng K, van Rooijen N, Geiben-Lynn R. Regulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbeta. PLoS One. 2010;5:e12281 (page 1-8).
47. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y, et al. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol. 1999;163:4647-50.
48. Ahn JK, Chung H, Lee DS, Yu YS, Yu HG. CD8b right CD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis. J Immunol. 2005;175:6133-42.
49. Takeno M, Shimoyama Y, Kashiwakura J, Nagafuchi H, Sakane T, Suzuki N. Abnormal killer inhibitory receptor expression on natural killer cells in patients with Beh ç et's disease. Rheumatol Int. 2004; 24:212-6.
50. Lee M, Choi B, Kwon HJ, Shim J, Park KS, Lee ES, Sohn S. The role of Qa-2, the functional HLA-G, in a Behcet's disease-like mouse model induced by the herpes simplex virus. J Infl amm (Lond). 2010;7:31 (page 1-12).
51. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential for TGF-beta to convert naive CD4+ CD25-cells to CD25+ Foxp3+ regulatory T cells and for expansion of these cells. J Immunol. 2007;178:2018-27.
52. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol. 2007;8:457-62.
53. Baecher-Allan C, Hafler DA. Suppressor T cells in human diseases. J Exp Med. 2004;200:273-6.
54. McGeachy MJ, Stephens LA, Anderton SM. Natural recovery and protection from autoimmune encephalomyelitis: Contribution of CD4+ CD25+ regulatory cells within the central nervous system. J Immunol. 2005;175:3025-32.
55. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med. 2004;199:971-9.
56. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, et al. Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 1998;10:1969-80.
57. Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, et al. Interleukin-10 is involved in the sup pression of experimental autoimmune encephalomyelitis by CD25+ CD4+ regulatory T cells. Int Immunol. 2004;16:249-56.
58. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and induced CD4+ CD25+ cells educate CD4+ CD25-cells to develop suppressive activity: The role of IL-2, TGF-beta, and IL-10. J Immunol. 2004;72:5213-21.
59. Chai JG, Coe D, Chen D, Simpson E, Dyson J, Scott D. In vitro expansion improves in vivo regulation by CD4+ CD25+ regulatory T cells. J Immunol. 2008;180:858-69.
60. Mosmann TR, Coffman RL. Th1 and Th2 cell: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145-73.
61. Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8:345-50.
62. Wan S, Xia C, Morel L. IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+ CD25+ T cell regulatory functions. J Immunol. 2007;178:271-9.
63. Yamakawa Y, Sugita Y, Nagatani T, Takahashi S, Yamakawa T, Tanaka S, et al. Interleukin-6 in patients with Behcet's disease. J Dermatol Sci. 1996;11:189-95.
64. Ichiyama K, Yoshida H, Wakabayashi Y, Chinen T, Saeki K, Nakaya M, et al. Foxp3 inhibits ROR{gamma}t-mediated IL-17A mRNA transcription through direct interaction with ROR{gamma}t. J Biol Chem. 2008;283:17003-8.
65. Shim J, Byun HO, Lee YD, Lee ES, Sohn S. Interleukin-6 small interfering RNA improved the herpes simplex virusinduced systemic infl ammation in vivo mouse model. Gene Ther. 2009;16:415-25.
66. Choi B, Hwang Y, Kwon HJ, Lee ES, Park KS, Bang D, et al. Tumor necrosis factor alpha interfering RNA decreases herpes simplex virus-induced infl ammation in a mouse model. J Dermatol Sci. 2008;52:87-97.